Search - tctmd.com

Displaying 21 - 40 of 54

Sort: Relevancy | Date

Presentation TCT 2014

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Presenter: Jonathan M. Hill, Hyo-Soo Kim, Emerson C. Perin, Daniel Suerder, MD

September 15, 2014

Presentation TCT 2014

Enhanced Effects of Primed Peripheral Monocytes

Presenter: Henricus J. Duckers, Stephen E. Epstein, Marc S. Penn, Hyo-Soo Kim

September 15, 2014

Presentation TCT 2014

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Presenter: Hyo-Soo Kim

September 14, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

July 10, 2014

News Daily News

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

July 10, 2014

Presentation Cell Therapy 2014

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Presenter: Hyo-Soo Kim

January 22, 2014

Presentation Cell Therapy 2014

Induction of Endothelial Cell from Fibroblast by 5 Defined Factors

Presenter: Hyo-Soo Kim

January 21, 2014

Presentation TCT 2013

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

Presenter: Hyo-Soo Kim

October 28, 2013

News Daily News

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

Yael L. Maxwell

September 20, 2013

News Daily News

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Yael L. Maxwell

September 20, 2013

News Daily News

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Yael L. Maxwell

September 20, 2013

Presentation ACC 2013

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Presenter: Hyo-Soo Kim

March 08, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

Presentation TCT 2013

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention

Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

January 31, 2013

Presentation Cell Therapy 2013

Scaled-up Method for Cardiosphere Derivation

Presenter: Hyo-Soo Kim

January 23, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

Presentation TCT 2012

Stents and Vascular Healing: New Concepts

Presenter: Hyo-Soo Kim

October 22, 2012

News Daily News

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Jason Kahn

August 24, 2012

Advertisement

TCT 149: Intracoronary Injection of Bone Marrow-Derived Mononuclear Cells, Early or Late After Acute Myocardial Infarction: Long-term Effects on Global Left Ventricular Function Twelve-Month MRI and Long-term Clinical Results of the SWISS-AMI Trial

Enhanced Effects of Primed Peripheral Monocytes

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

Cytokine-based peripheral blood stem cell therapy: MAGIC Cell-5-combicytokine trial

Induction of Endothelial Cell from Fibroblast by 5 Defined Factors

The Promus Element Everolimus-Eluting Stent: Design Considerations and Clinical Trial Results (from PLATINUM to HOST-ASSURE)

在使用DES接受PCI治疗的患者中，西洛他唑与双倍剂量氯吡格雷一样安全

El Cilostazol es Seguro como la Dosis Doble de Clopidogrel en Pacientes sometidos a PCI con un SLF

Cilostazol as Safe as Double-Dose Clopidogrel in Patients Undergoing PCI with DES

Randomized Comparison of PtCr-EES vs CoCr-ZES in All-Comers Receiving PCI: The HOST-ASSURE Randomized Trial

Pair of Studies Show Positive Stent Results at ACC

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention

Scaled-up Method for Cardiosphere Derivation

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Stents and Vascular Healing: New Concepts

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content